Colonoscopy used to identify and remove flat colon lesions

Key points
- The study appears in the March 5 issue of the Journal of the American Medical Association.
- Each year nearly 150,000 people are diagnosed with colon cancer and almost 50,000 die from the disease annually in the United States.
- Founded in 1941, the mission of the American Society for Gastrointestinal Endoscopy is to be the leader in advancing patient care and digestive health by promoting excellence in gastrointestinal endoscopy.
- Endoscopy is performed by specially-trained physicians called endoscopists using the most current technology to diagnose and treat diseases of the gastrointestinal tract.
A study released this week from researchers at the Veterans Affairs Palo Alto Healthcare System in California shows that non-polypoid colorectal neoplasms or flat colon lesions, are more common in Americans than previously thought and may have a greater association with cancer compared to polypoid neoplasms or the more commonly diagnosed colorectal polyp. The study appears in the March 5 issue of the Journal of the American Medical Association. Researchers identified these flat lesions through colonoscopy.
“This study is very significant, as these flat lesions are more difficult to detect than the typical polyp during colorectal cancer screening,” said Grace H. Elta, MD, FASGE, president of the American Society for Gastrointestinal Endoscopy (ASGE). “Researchers identified these lesions in their study through colonoscopy, which has the ability to detect lesions of all sizes and is the only procedure that allows for the removal of lesions and polyps. Studies have shown that other imaging methods are ineffective at identifying even small polyps and miss flat lesions entirely. This study highlights the importance of quality colonoscopy screening. ASGE, as the standard-setting society for endoscopy, has issued quality indicators for colorectal cancer screening that define measures for improving quality in colonoscopy.”
Flat lesions are challenging to detect because subtle findings through examination can be difficult to distinguish from the normal mucosa. As compared with the surrounding normal mucosa, the flat lesions appear to be slightly elevated, completely flat or slightly depressed.
The study examined data from a group of 1,819 patients, almost all men with an average age of 64, from July 2003 to June 2004 undergoing elective colonoscopy to estimate the prevalence of non-polypoid colorectal neoplasms (NP-CRNs), or flat lesions, and to characterize their association with colorectal cancer. Patients were divided into three groups; screening, surveillance and a group of patients with symptoms for colorectal cancer. Flat lesions were found in 170 people, approximately 10 percent. The surveillance group had the highest incidence with more than 15 percent who had flat lesions. Approximately six percent of the screening and symptoms groups had flat lesions. Researchers found that the flat growths were five times more likely to be cancerous than polyps.
“Experts in gastrointestinal endoscopy will need to be more vigilant than ever in encouraging their patients to take their bowel prep as directed before the colonoscopy. Proper bowel prep is important so that the physician can clearly see the colon. This study also highlights the importance of not withdrawing too soon during the procedure, allowing the physician enough time to thoroughly examine the colon. According to ASGE quality indicators, withdrawal time should be six minutes or more. ASGE will continue to provide training and education to physicians to ensure that patients are receiving the highest quality of care possible,” said Elta.
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsMolecular marker from pancreatic 'juices' helps identify pancreatic cancer
Researchers at Mayo Clinic have developed a promising method to distinguish between pancreatic cancer and chronic pancreatitis - two disorders that are difficult to tell apart. A molecular marker obtained from…
20 May 2013
NewsPenn Medicine researchers identify 4 new genetic risk factors for testicular cancer
A new study looking at the genomes of more than 13,000 men identified four new genetic variants associated with an increased risk of testicular cancer , the most commonly diagnosed type in young men today. The findings…
13 May 2013
NewsCommonly used drug can limit radiation damage to lungs and heart for cancer patients
Geneva, Switzerland: Unavoidable damage caused to the heart and lungs by radiotherapy treatment of tumours in the chest region can be limited by the administration of an ACE inhibitor, a drug commonly used in the…





